1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
von Palffy, Sofia LU ; Thorsson, Hanna LU ; Peña-Martínez, Pablo LU ; Puente-Moncada, Noelia LU ; Sandén, Carl LU ; Blom, Anna M LU
; Henningsson, Rasmus
LU
; Juliusson, Gunnar
LU
; King, Ben
LU
and Landberg, Niklas
LU
, et al.
(2023)
In Blood Advances
7(7).
p.1204-1218
- Contribution to journal › Article
-
Mark
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability
Thomas, Daniel ; Wu, Manhong ; Nakauchi, Yusuke ; Zheng, Ming ; Thompson-Peach, Chloe A L ; Lim, Kelly ; Landberg, Niklas LU
; Köhnke, Thomas
; Robinson, Nirmal
and Kaur, Satinder
, et al.
(2023)
In Cancer Discovery
13(2).
p.496-515
- Contribution to journal › Article
-
Mark
Reprogramming Cancer into Antigen Presenting Cells as a Novel Immunotherapy
- Contribution to journal › Article
- 2021
-
Mark
Clinical and genomic characterization of patients diagnosed with the provisional entity Acute myeloid leukemia with BCR-ABL1, a Swedish population-based study
Orsmark-Pietras, Christina LU ; Landberg, Niklas LU
; Lorenz, Fryderyk
; Uggla, Bertil
; Höglund, Martin
; Lehmann, Sören
; Derolf, Åsa
; Deneberg, Stefan
; Antunovic, Petar
and Cammenga, Jörg
LU
, et al.
(2021)
In Genes, Chromosomes and Cancer
60(6).
p.426-433
- Contribution to journal › Article
- 2020
-
Mark
A high-content cytokine screen identifies myostatin propeptide as a positive regulator of primitive chronic myeloid leukemia cells
von Palffy, Sofia LU ; Landberg, Niklas LU
; Sandén, Carl
LU
; Zacharaki, Dimitra
LU
; Shah, Mansi
; Nakamichi, Naoto
; Hansen, Nils
LU
; Askmyr, Maria
LU
; Lilljebjörn, Henrik
LU
and Rissler, Marianne
LU
, et al.
(2020)
In Haematologica
105(8).
p.2095-2104
- Contribution to journal › Article
-
Mark
Cell Surface Markers as Therapeutic Targets in Myeloid Leukemia
- Thesis › Doctoral thesis (compilation)
-
Mark
Clonal competition within complex evolutionary hierarchies shapes AML over time
Sandén, Carl LU ; Lilljebjörn, Henrik LU
; Orsmark Pietras, Christina
LU
; Henningsson, Rasmus
LU
; Saba, Karim H.
LU
; Landberg, Niklas
LU
; Thorsson, Hanna
LU
; von Palffy, Sofia
LU
; Peña-Martinez, Pablo
LU
and Högberg, Carl
LU
, et al.
(2020)
In Nature Communications
11(1).
- Contribution to journal › Article
- 2018
-
Mark
CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting
Landberg, Niklas LU
; von Palffy, Sofia
LU
; Askmyr, Maria
LU
; Lilljebjörn, Henrik
LU
; Sandén, Carl
LU
; Rissler, Marianne
LU
; Mustjoki, Satu
; Hjorth-Hansen, Henrik
; Richter, Johan
LU
and Ågerstam, Helena
LU
, et al.
(2018)
In Haematologica
103(3).
p.447-455
- Contribution to journal › Article
- 2017
-
Mark
Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells
Askmyr, Maria LU ; Von Palffy, Sofia LU ; Hansen, Nils LU ; Landberg, Niklas LU
; Högberg, Carl
LU
; Rissler, Marianne
LU
; Ågerstam, Helena
LU
and Fioretos, Thoas
LU
(2017)
In PLoS ONE
12(10).
- Contribution to journal › Article
-
Mark
Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib
Landberg, Niklas LU
; Dreimane, Arta
; Rissler, Marianne
LU
; Billström, Rolf
and Ågerstam, Helena
LU
(2017)
In European Journal of Haematology
99(5).
p.442-448
- Contribution to journal › Article